Gold prices slip slightly after recent gains; U.S. data eyed
Barry M. Smith, a director at Ensign Group, Inc. (NASDAQ:ENSG), sold 700 shares of the company’s common stock on March 3, 2025. The shares were sold at an average price of $129.15 each, amounting to a total transaction value of $90,405. Following this sale, Smith retains ownership of 30,052 shares in the company. The healthcare services provider, currently valued at $7.47 billion, has demonstrated strong financial performance with a 14.2% revenue growth over the last twelve months. According to InvestingPro analysis, the company maintains a GOOD financial health score and trades slightly above its Fair Value.
This transaction was carried out under a pre-established Rule 10b5-1 trading plan, which Smith adopted on July 31, 2024. Such plans allow insiders to set up a predetermined schedule for buying or selling stock, providing a defense against potential accusations of insider trading. InvestingPro subscribers can access 10 additional key insights about Ensign Group, including its 18-year dividend growth streak and analyst forecasts. Get the complete picture with the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, The Ensign Group has seen its stock target raised by analysts at both Stephens and Macquarie, reflecting confidence in the company’s growth trajectory. Stephens analyst Scott Fidel increased the price target to $160, maintaining an Overweight rating, citing the company’s consistent mid-teens growth in revenue and adjusted earnings per share over the past decade. Fidel also highlighted The Ensign Group’s strategic focus on mergers and acquisitions to expand its market presence in states like Alabama, Oregon, and South Carolina. Meanwhile, Macquarie analyst Tao Qiu lifted the price target to $166, keeping an Outperform rating, based on expectations that the company will surpass current consensus estimates for 2025.
Since late September 2024, The Ensign Group has announced 30 acquisitions, which include a mix of leased and owned facilities, indicating a robust pipeline. Macquarie projects revenue growth between 12.5% and 15.0% for 2025, driven by both organic growth and acquisitions. This projection is above the consensus revenue estimate of $4,774 million for the year. Analysts from both firms emphasize the company’s strategic M&A activity and strong organic growth drivers as key factors in its ongoing success. The Ensign Group’s management is expected to provide an initial outlook for 2025 that exceeds current consensus estimates, with potential for further upward revisions throughout the year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.